Alamar Biosciences, Inc.(ALMR)— Stock Profile, AI Score & Financials

Technology · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Alamar Biosciences, Inc. (ALMR) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. ALMR is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q2 2026), Alamar Biosciences, Inc. reports quarterly revenue of $29.4M, net income of $-13.2M, an operating margin of -46.0%. Top institutional holders of ALMR by reported 13-F value include Sands Capital Ventures, Samsara BioCapital, T. Rowe Price Investment Management, based on the most recent SEC filings. ALMR trades on the Nasdaq exchange and files with the SEC under CIK 2104204. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALMR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alamar Biosciences, Inc. directly from SEC EDGAR.